CRWD vs VRTV: Which Is the Better Buy?

Side-by-side comparison of CrowdStrike Holdings, Inc. and Veritiv Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
CrowdStrike Holdings, Inc. Β· Technology
$259.67
-13.1% upside to fair value
Low Conviction Grade C High Quality
VS
Veritiv Corporation Β· Industrials
$169.99
-45.0% upside to fair value
Med Conviction Grade D
QuantHub Verdict
CRWD has more upside to fair value (-13.1%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric CRWD VRTV
Current Price $259.67 $169.99
Fair Value Estimate $225.56 $93.49
Upside to Fair Value -13.1% -45.0%
Market Cap $264.4B $2.3B
Forward P/E β€” β€”
EV / EBITDA 595.7x 5.4x
Price / Sales 49.0x 0.4x
Price / FCF 167.9x 10.4x
Revenue Growth YoY +25.8% -19.0%
Gross Margin 75.2% 22.7%
Operating Margin -2.2% 5.9%
Return on Equity 1.3% 48.6%
Dividend Yield 0% 1.48%
FCF Yield 0.6% 9.57%
Analyst Consensus Strong Buy Hold
Investment Thesis
CRWD β€” CrowdStrike Holdings, Inc.
CrowdStrike Holdings is a cloud-native cybersecurity platform company that sells subscriptions to its Falcon platform and a growing array of cloud modules spanning endpoint protection, cloud workload security, identity protection, Next-Gen SIEM, threat intelligence, and managed services, generating revenue through a direct sales force and channel partners from its Austin, Texas headquarters with …
VRTV β€” Veritiv Corporation
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
Metric CRWD VRTV
Zone Low $169.17 $70.12
Zone High $191.73 $79.47
In Buy Zone? No No
← CRWD Research    VRTV Research β†’    All Research